Bloomberg: U.S. intends to buy 500 million doses of vaccine from Pfizer for countries in need
Washington is in talks with U.S. company Pfizer to purchase 500 million doses of coronavirus vaccine to give to countries in need. This was reported on Saturday by Bloomberg news agency.
According to its source, the deal between Joe Biden’s administration and the pharmaceutical company that produces vaccines in cooperation with its German partner BioNTech may be concluded in the coming days. It will be announced ahead of the COVID-19 summit scheduled for September 22. The meeting, convened at the initiative of Biden, will take place in a virtual format.
The 500 million doses of vaccine are expected to be distributed to countries in need through the international mechanism COVAX.
The White House had already struck a similar deal with Pfizer in June, but deliveries of the drug have been slow. This leads to the fact that “in many of the less affluent COVAX member countries, only a fraction of the population has been vaccinated so far.